Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1979
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01DC04
|
| gptkbp:bioavailability |
95%
|
| gptkbp:CASNumber |
53994-73-3
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:eliminationHalfLife |
0.6-0.9 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C15H14ClN3O4S
|
| gptkbp:indication |
bacterial infections
|
| gptkbp:isA |
gptkb:second-generation_cephalosporin
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
367.81 g/mol
|
| gptkbp:name |
gptkb:Cefaclor
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
25%
|
| gptkbp:PubChem_CID |
gptkb:DB320
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
allergic reactions
gastrointestinal disturbances serum sickness-like reaction |
| gptkbp:synonym |
gptkb:Ceclor
Cefaclorum |
| gptkbp:target |
penicillin-binding proteins
|
| gptkbp:bfsParent |
gptkb:Royal_Cache_(TT320)
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
DB320
|